A frantic grant-writing effort that has consumed biomedical research scientists this spring came to an end last week, resulting in a huge pile of new applications—more than 10 times larger than expected—to be reviewed by the National Institutes of Health (NIH). After this enthusiastic response, there will be many disappointed applicants: The rejection rate could run as high as 98%.